Staab Thomas R Ii - Net Worth and Insider Trading

Staab Thomas R Ii Net Worth

The estimated net worth of Staab Thomas R Ii is at least $958,557 dollars as of 2024-04-29. Staab Thomas R Ii is the Senior Vice President and CFO of BioCryst Pharmaceuticals Inc and owns about 125,176 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $520,732. Staab Thomas R Ii is also the CFO of LENSAR Inc and owns about 135,131 shares of LENSAR Inc (LNSR) stock worth over $437,824. Details can be seen in Staab Thomas R Ii's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Staab Thomas R Ii has not made any transactions after 2022-12-07 and currently still holds the listed stock(s).

Transaction Summary of Staab Thomas R Ii

To

Staab Thomas R Ii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Staab Thomas R Ii owns 2 companies in total, including LENSAR Inc (LNSR) , and BioCryst Pharmaceuticals Inc (BCRX) .

Click here to see the complete history of Staab Thomas R Ii’s form 4 insider trades.

Insider Ownership Summary of Staab Thomas R Ii

Ticker Comapny Transaction Date Type of Owner
LNSR LENSAR Inc 2022-12-07 Chief Financial Officer
BCRX BioCryst Pharmaceuticals Inc 2019-05-17 Senior Vice President and CFO

Staab Thomas R Ii Latest Holdings Summary

Staab Thomas R Ii currently owns a total of 2 stocks. Among these stocks, Staab Thomas R Ii owns 125,176 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 17, 2019, with a value of $520,732 and a weighting of 54.32%. Staab Thomas R Ii also owns 135,131 shares of LENSAR Inc (LNSR) as of December 7, 2022, with a value of $437,824 and a weighting of 45.68%.

Latest Holdings of Staab Thomas R Ii

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2019-05-17 125,176 4.16 520,732
LNSR LENSAR Inc 2022-12-07 135,131 3.24 437,824

Holding Weightings of Staab Thomas R Ii


Staab Thomas R Ii Form 4 Trading Tracker

According to the SEC Form 4 filings, Staab Thomas R Ii has made a total of 4 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 9,750 shares on May 17, 2019, which brought Staab Thomas R Ii around $74,588.

According to the SEC Form 4 filings, Staab Thomas R Ii has made a total of 1 transactions in LENSAR Inc (LNSR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in LENSAR Inc is the acquisition of 2,752 shares on December 7, 2022, which cost Staab Thomas R Ii around $8,696.

Insider Trading History of Staab Thomas R Ii

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Staab Thomas R Ii Trading Performance

GuruFocus tracks the stock performance after each of Staab Thomas R Ii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Staab Thomas R Ii is -1.88%. GuruFocus also compares Staab Thomas R Ii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Staab Thomas R Ii within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Staab Thomas R Ii's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Staab Thomas R Ii

Average Return

-28.53%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -17.55 -1.88 4.08 -28.53
Relative Return to S&P 500(%) -16.56 -3.21 -4.4 -45.1

Staab Thomas R Ii Ownership Network

Ownership Network List of Staab Thomas R Ii

No Data

Ownership Network Relation of Staab Thomas R Ii


Staab Thomas R Ii Owned Company Details

What does LENSAR Inc do?

Who are the key executives at LENSAR Inc?

Staab Thomas R Ii is the Chief Financial Officer of LENSAR Inc. Other key executives at LENSAR Inc include 10 percent owner North Run Capital, Lp , 10 percent owner North Run Advisors, Llc , and director & 10 percent owner Thomas B Ellis .

LENSAR Inc (LNSR) Insider Trades Summary

Over the past 18 months, Staab Thomas R Ii made 1 insider transaction in LENSAR Inc (LNSR) with a net purchase of 2,752. Other recent insider transactions involving LENSAR Inc (LNSR) include a net purchase of 9,505 shares made by Gary M Winer , a net purchase of 50,000 shares made by Aimee S Weisner ,

In summary, during the past 3 months, insiders sold 0 shares of LENSAR Inc (LNSR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LENSAR Inc (LNSR) were sold and 62,257 shares were bought by its insiders, resulting in a net purchase of 62,257 shares.

LENSAR Inc (LNSR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

LENSAR Inc Insider Transactions

No Available Data

Staab Thomas R Ii Mailing Address

Above is the net worth, insider trading, and ownership report for Staab Thomas R Ii. You might contact Staab Thomas R Ii via mailing address: C/o Inspire Pharmaceuticals, Inc., 4222 Emperor Blvd., Suite 200, Durham Nc 27703.

Discussions on Staab Thomas R Ii

No discussions yet.